| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZNF609_0004500 | Intron-Intron | chr15:64808854-64809781 | chr15:64516655-64517582 | 928 nt | 0.3901 |
| hsa_ZNF609_0004600 | Intron-Intron | chr15:64810312-64810493 | chr15:64518113-64518294 | 182 nt | 0.3956 |
| hsa_ZNF609_0004700 | Intron-Intron | chr15:64812211-64854057 | chr15:64520012-64561858 | 250 nt | 0.3520 |
| hsa_chr15_0217100 | Intergenic-Intergenic | chr15:64815730-64819097 | chr15:64523531-64526898 | 250 nt | 0.3840 |
| hsa_ZNF609_0004900 | Intron-Intron | chr15:64816913-64817701 | chr15:64524714-64525502 | 789 nt | 0.3283 |
| hsa_ZNF609_0005000 | Intron-Intron | chr15:64817423-64817655 | chr15:64525224-64525456 | 233 nt | 0.3433 |
| hsa_chr15_0217200 | Intergenic-Intergenic | chr15:64818913-64819097 | chr15:64526714-64526898 | 185 nt | 0.4973 |
| hsa_ZNF609_0005100 | Intron-Intron | chr15:64822165-64829425 | chr15:64529966-64537226 | 250 nt | 0.4440 |
| hsa_chr15_0217300 | Intergenic-Intergenic | chr15:64822178-64826971 | chr15:64529979-64534772 | 250 nt | 0.3760 |
| hsa_chr15_0217400 | Intergenic-Intergenic | chr15:64826455-64826971 | chr15:64534256-64534772 | 517 nt | 0.5068 |
A study in mice demonstrated that the circZNF609 exhibits higher expression in myotubes compared to myoblasts, and its downregulation reduces myoblast proliferation while inhibiting differentiation by sponging miR-194-5p and upregulating BCLAF1 [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review consolidating research across multiple species, including human, mouse, rat, and C. elegans, indicates that the circZNF609 is downregulated in Hirschsprung disease and functions as a miRNA sponge for miR-150-5p to regulate AKT3, where its silencing inhibits cell migration and proliferation [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. In mammalian neural tissue, it is also noted to play a role in myoblast differentiation by producing a protein [Suresh L. Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].